Position in ABBV
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$10,067,109
+$387,935 QoQ
Shares Held
40,006
-10.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#916
of 4,153 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BDF-GESTION holds $47,173,274 across 6 Drug Manufacturers - General names. ABBV ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,034 | $21,630,522 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
40,006 | $10,067,109 | |
| 3 | MRK |
Merck & Co., Inc.
|
42,451 | $5,454,953 | |
| 4 | JNJ |
Johnson & Johnson
|
20,620 | $5,236,861 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,801 | $2,754,338 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
35,222 | $2,029,491 |
All Filings in ABBV
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,067,109 | 40,006 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $9,679,174 | 44,504 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $10,168,718 | 44,504 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $7,993,223 | 34,522 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $7,740,354 | 41,700 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $11,284,956 | 53,861 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $9,571,099 | 53,861 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $12,018,040 | 60,857 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $10,438,192 | 60,857 | Shares | Sole | 2024-07-11 | |
| No filing history on record for this holder in this stock. | ||||||